Clinical Trials Directory

Trials / Completed

CompletedNCT01774643

A Study of Pancreatic Cancer in Xenografts From Liver Metastases

A Feasibility Study Of Developing Murine Primary Xenografts From Biopsies Of Liver Metastases In Patients With Advanced Pancreatic Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
31 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a feasibility study to perform image-guided liver biopsies in 25 patients who have pancreatic cancer with liver metastasis (cancer in the pancreas that has spread to the liver). This will contribute with samples for the bio-bank (bank of tumors) and develop xenografts (human tumors growing in mice) for further analysis of genes.

Detailed description

This study might bring a better understanding of the metastatic pancreatic cancer and evaluate the differences between the metastatic and the primary pancreatic cancer (the type that does not have metastasis).

Conditions

Timeline

Start date
2013-01-01
Primary completion
2015-04-01
Completion
2022-11-01
First posted
2013-01-24
Last updated
2023-01-10

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01774643. Inclusion in this directory is not an endorsement.